Incorporating acute HIV screening into routine HIV Testing at sexually transmitted infection clinics, and HIV testing and counseling centers in Lilongwe, Malawi

Journal of Acquired Immune Deficiency Syndromes

Volumn 71, Issue 3, 2016, Pages 272-280

  Rutstein, Sarah E ^a,b   Pettifor, Audrey E ^a   Phiri, Sam ^c   Kamanga, Gift ^d   Hoffman, Irving F ^b   Hosseinipour, Mina C ^b,d   Rosenberg, Nora E ^d   Nsona, Dominic ^c   Pasquale, Dana ^a   Tegha, Gerald ^d   Powers, Kimberly A ^a   Phiri, McLeod ^c   Tembo, Bisweck ^c   Chege, Wairimu ^e   Miller, William C ^a,b  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c LIGHTHOUSE TRUST   (Malawi)

^d UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Acute HIV infection; AHI screening; HIV testing and counseling; Malawi

Indexed keywords

ANTIBODY; VIRUS RNA;

ACUTE HIV TESTING; ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HIV RAPID TEST; HIV TEST; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALAWI; MALE; MIDDLE AGED; MULTICENTER STUDY; PATIENT COUNSELING; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SEXUALLY TRANSMITTED DISEASE; VIRUS LOAD; VIRUS STRAIN; VIRUS TRANSMISSION; YOUNG ADULT; ADOLESCENT; BLOOD; HIV INFECTIONS; OUTPATIENT DEPARTMENT; PREVALENCE; STANDARDS; VIROLOGY;

ADOLESCENT; ADULT; AMBULATORY CARE FACILITIES; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HUMANS; MALAWI; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; RNA, VIRAL; VIRAL LOAD; YOUNG ADULT;

EID: 84959112030     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000853     Document Type: Article

References (41)

1. Pilcher CD, Shugars DC, Fiscus SA, et al. HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health. AIDS. 2001;15:837-845.
2. Vaidya NK, Ribeiro RM, Miller CJ, et al. Viral dynamics during primary simian immunodeficiency virus infection: effect of time-dependent virus infectivity. J Virol. 2010;84:4302-4310.
3. Ma ZM, Stone M, Piatak M Jr, et al. High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection. J Virol. 2009;83:3288-3297.
4. Pilcher CD, Joaki G, Hoffman IF, et al. Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS. 2007;21:1723-1730.
5. Morrison CS, Demers K, Kwok C, et al. Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection. AIDS. 2010;24:573-582.
6. Brenner BG, Roger M, Routy JP, et al. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis. 2007;195:951-959.
7. Cohen MS, Shaw GM, McMichael AJ, et al. Acute HIV-1 infection. N Engl J Med. 2011;364:1943-1954.
8. Miller WC, Rosenberg NE, Rutstein SE, et al. Role of acute and early HIV infection in the sexual transmission of HIV. Curr Opin HIV AIDS. 2010;5:277-282.
9. Pilcher CD, Tien HC, Eron JJ Jr, et al. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis. 2004;189: 1785-1792.
10. Cohen MS, McCauley M, Gamble TR. HIV treatment as prevention and HPTN 052. Curr Opin HIV AIDS. 2012;7:99-105.
11. Powers KA, Ghani AC, Miller WC, et al. The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet. 2011;378:256-268.
12. White PJ, Fox J, Weber J, et al. How many HIV infections may be averted by targeting primary infection in men who have sex with men? Quantification of changes in transmission-risk behavior, using an individual-based model. J Infect Dis. 2014;210(suppl 2):S594-S599.
13. Marks G, Crepaz N, Senterfitt JW, et al. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39:446-453.
14. Steward WT, Remien RH, Higgins JA, et al. Behavior change following diagnosis with acute/early HIV infection - a move to serosorting with other HIV-infected individuals. The NIMH Multisite Acute HIV Infection Study. III. AIDS Behav. 2009;13:1054-1060.
15. Gous N, Scott L, Perovic O, et al. Should South Africa be performing nucleic acid testing on HIV enzyme-linked immunosorbent assaynegative samples? J Clin Microbiol. 2010;48:3407-3409.
16. Juusola JL, Brandeau ML, Long EF, et al. The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA. AIDS. 2011;25:1779-1787.
17. Karris MY, Anderson CM, Morris SR, et al. Cost savings associated with testing of antibodies, antigens, and nucleic acids for diagnosis of acute HIV infection. J Clin Microbiol. 2012;50:1874-1878.
18. Cragin L, Pan F, Peng S, et al. Cost-effectiveness of a fourth-generation combination immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen for the detection of HIV infections in the United States. HIV Clin Trials. 2012;13:11-22.
19. Bebell LM, Pilcher CD, Dorsey G, et al. Acute HIV-1 infection is highly prevalent in Ugandan adults with suspected malaria. AIDS. 2010;24: 1945-1952.
20. Sanders EJ, Mugo P, Prins HA, et al. Acute HIV-1 infection is as common as malaria in young febrile adults seeking care in coastal Kenya. AIDS. 2014;28:1357-1363.
21. Serna-Bolea C, Munoz J, Almeida JM, et al. High prevalence of symptomatic acute HIV infection in an outpatient ward in southern Mozambique: identification and follow-up. AIDS. 2010;24:603-608.
22. Bassett IV, Chetty S, Giddy J, et al. Screening for acute HIV infection in South Africa: finding acute and chronic disease. HIV Med. 2011;12:46-53.
23. Pilcher CD, Price MA, Hoffman IF, et al. Frequent detection of acute primary HIV infection in men in Malawi. AIDS. 2004;18:517-524.
24. Fiscus SA, Pilcher CD, Miller WC, et al. Rapid, real-time detection of acute HIV infection in patients in Africa. J Infect Dis. 2007;195:416-424.
25. Rutstein SE, Pettifor A, Phiri S, et al. Identifying persons with acute HIV infection in urban Malawi HIV testing and sexually transmitted infection clinics: an opportunity for HIV transmission prevention. Paper presented at: 20th International AIDS Conference; July 2014; Melbourne, Australia.
26. Powers KA, Miller WC, Pilcher CD, et al. Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm. AIDS. 2007;21:2237-2242.
27. Global AIDS Response Progress Report: Malawi Progress report for 2013. Lilongwe: Ministry of Health; 2014.
28. Westreich DJ, Hudgens MG, Fiscus SA, et al. Optimizing screening for acute human immunodeficiency virus infection with pooled nucleic acid amplification tests. J Clin Microbiol. 2008;46:1785-1792.
29. Pilcher CD, McPherson JT, Leone PA, et al. Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. JAMA. 2002;288:216-221.
30. Priddy FH, Pilcher CD, Moore RH, et al. Detection of acute HIV infections in an urban HIV counseling and testing population in the United States. J Acquir Immune Defic Syndr. 2007;44:196-202.
31. Pilcher CD, Fiscus SA, Nguyen TQ, et al. Detection of acute infections during HIV testing in North Carolina. N Engl J Med. 2005;352:1873-1883.
32. Wolpaw BJ, Mathews C, Chopra M, et al. Diagnosis and counselling of patients with acute HIV infection in South Africa. Sex Transm Infect. 2011;87:71-72.
33. Wahome E, Fegan G, Okuku HS, et al. Evaluation of an empiric risk screening score to identify acute and early HIV-1 infection among MSM in Coastal Kenya. AIDS. 2013;27:2163-2166.
34. Braun DL, Kouyos RD, Balmer B, et al. Frequency and spectrum of unexpected clinical manifestations of primary HIV-1 infection. Clin Infect Dis. 2015;61:1013-1021.
35. Wood E, Kerr T, Rowell G, et al. Does this adult patient have early HIV infection?: the Rational Clinical Examination systematic review. JAMA. 2014;312:278-285.
36. Conway DP, Holt M, McNulty A, et al. Multi-centre evaluation of the Determine HIV Combo assay when used for point of care testing in a high risk clinic-based population. PLoS One. 2014;9: e94062.
37. Duong YT, Mavengere Y, Patel H, et al. Poor performance of the Determine HIV-1/2 Ag/Ab combo fourth-generation rapid test for detection of acute infections in a National Household Survey in Swaziland. J Clin Microbiol. 2014;52:3743-3748.
38. Rosenberg NE, Kamanga G, Phiri S, et al. Detection of acute HIV infection: a field evaluation of the determine(R) HIV-1/2 Ag/Ab combo test. J Infect Dis. 2012;205:528-534.
39. Long EF. HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis. PLoS One. 2011;6:e27625.
40. Hutchinson AB, Patel P, Sansom SL, et al. Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after thirdgeneration HIV antibody screening and rapid testing in the United States: a comparison of three public health settings. Plos Med. 2010;7:e1000342.
41. Krajden M, Cook D, Mak A, et al. Pooled nucleic acid testing increases the diagnostic yield of acute HIV infections in a high-risk population compared to 3rd and 4th generation HIV enzyme immunoassays. J Clin Virol. 2014;61:132-137.